Contact Info
Stuart Chalk, Ph.D.
Department of Chemistry
University of North Florida
Phone: 1-904-620-1938
Fax: 1-904-620-3535
Email: schalk@unf.edu
Website: @unf
Procainamide
- IUPAC Name: 4-amino-N-[2-(diethylamino)ethyl]benzamide
- Molecular Formula: C13H21N3O
- CAS Registry Number: 51-06-9
- InChI: InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)
- InChI Key: REQCZEXYDRLIBE-UHFFFAOYSA-N
Citations 1
"More-sensitive Enzyme-multiplied Immunoassay Technique For Procainamide And N-acetylprocainamide In Plasma, Serum And Urine"
Clin. Chem.
1988 Volume 34, Issue 5 Pages 957-960
PR Henry and RA Dhruv
Abstract:
Procainamide(I) and N-acetylprocainamide(II) were determined by a commercial EMIT method (Syva Co.), modified to permit automated analysis of ~100 samples per day in a working range of 0.1 to 2.0 µg mL-1. A Gilford 203S continuous-flow system was used, with a Beckman Model DU spectrophotometer. The calibration graph was prepared by using I or II concentration. of 0, 0.1, 0.2, 1.6, 1.0 and 2.0 µg mL-1 and had a standard deviation of 5%. In a study in which 0.1 to 10 µg mL-1 of I and II were determined in duplicate, average recoveries, calculated from data obtained on two separate days were 99.5% (coefficient of variation 2.2%) and 100.4% (coefficient of variation 3.0%) for I and II, respectively. At extreme ratios of I to II the accuracy of determining the lower concentration. component became unsatisfactory.
Blood Plasma
Blood Serum
Urine
Clinical analysis
Spectrophotometry
Immunoassay
Simultaneous analysis